GSK’s Adult Shot Arexvy Bags European Approval

June 9, 2023

Six Things to Know in July 2022

December 10, 2022

BioAge Halts Phase 2 Obesity Study Just Two Months After IPO

December 13, 2024

Must Read

FDA Places Regenxbio Gene Therapies on Clinical Hold Weeks Before Approval Decision

January 30, 2026

Cellares Raises $257 Million Series D to Expand Global Cell Therapy Manufacturing

January 30, 2026

Eli Lilly Partners With Seamless Therapeutics to Develop Gene Editing Treatments for Hearing Loss

January 30, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

IntraBio Plans Regulatory Submissions for Aqneursa in Ataxia-Telangiectasia Following Phase 3 Results

Roche Reports Phase II Results for Obesity Drug CT-388 Showing Up to 22.5% Weight Loss

J&J Reports Phase 3 Results Showing Tecvayli Benefit as Monotherapy in Multiple Myeloma

BMS’ Camzyos Scores Big Trial Win, Expansion to Adolescent Patients Imminent

Eli Lilly Partners With Seamless Therapeutics to Develop Gene Editing Treatments for Hearing Loss

Eli Lilly Signs Immunology Collaboration With Repertoire Immune Medicines

Novo Nordisk Advances Cell Therapy Partnership With Aspect

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Reg impact assessment next in GenAI’s sights, experts claim

The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

Improving life science R&D outcomes with AI

The medical device sector’s surging regulatory burden: how are suppliers coping?

Commercial

Potentially tough road for BMS as immuno-oncology pricing war looms

Editor Picks

GSK’s Adult Shot Arexvy Bags European Approval

Six Things to Know in July 2022

BioAge Halts Phase 2 Obesity Study Just Two Months After IPO

Must Read

FDA Places Regenxbio Gene Therapies on Clinical Hold Weeks Before Approval Decision

Cellares Raises $257 Million Series D to Expand Global Cell Therapy Manufacturing

Eli Lilly Partners With Seamless Therapeutics to Develop Gene Editing Treatments for Hearing Loss

Hot Topics

About Us

Follow Us